rs7782939

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -14 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_ModerateBP6_Strong

The NM_001101426.4(CRPPA):c.55A>C (p.Ser19Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.304 (AC=394,087) in the gnomAD database across 1,297,340 control chromosomes, including 60,694 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.378. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★). This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.

Frequency

Genomes: 𝑓 0.30 ( 6867 hom., cov: 33)
Exomes 𝑓: 0.30 ( 53827 hom. )

Consequence

CRPPA
NM_001101426.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -1.69

Publications

16 publications found
Variant links:
Genes affected
CRPPA (HGNC:37276): (CDP-L-ribitol pyrophosphorylase A) This gene encodes a 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein. Mutations in this gene are the cause of Walker-Warburg syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, May 2012]
CRPPA Gene-Disease associations (from GenCC):
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • myopathy caused by variation in CRPPA
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, ClinGen
  • autosomal recessive limb-girdle muscular dystrophy type 2U
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital muscular dystrophy without intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001101426.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript

Our verdict: Benign. The variant received -14 points.

BP4
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Moderate).
BP6
ClinVar 2-star benign — strong (BP6); ClinVar submissions overwhelmingly benign (≥10 total, ≥80% B/LB, <10% P/LP) — strong (BP6, count-based); ClinVar germline classification: Benign/Likely Benign, 2 star(s). ClinVar submissions strongly and reliably favor benignity (11/11 total B/LB).
BA1
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.3782 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_001101426.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CRPPA
NM_001101426.4
MANE Select
c.55A>Cp.Ser19Arg
missense
Exon 1 of 10NP_001094896.1A4D126-1
CRPPA
NM_001368197.1
c.55A>Cp.Ser19Arg
missense
Exon 1 of 9NP_001355126.1
CRPPA
NM_001101417.4
c.55A>Cp.Ser19Arg
missense
Exon 1 of 9NP_001094887.1A0A140VJM1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CRPPA
ENST00000407010.7
TSL:5 MANE Select
c.55A>Cp.Ser19Arg
missense
Exon 1 of 10ENSP00000385478.2A4D126-1
CRPPA
ENST00000399310.3
TSL:1
c.55A>Cp.Ser19Arg
missense
Exon 1 of 9ENSP00000382249.3A4D126-2
CRPPA
ENST00000856526.1
c.55A>Cp.Ser19Arg
missense
Exon 1 of 8ENSP00000526585.1A0ACI8QS87

Frequencies

GnomAD3 genomes
AF:
0.299
AC:
45300
AN:
151428
Hom.:
6873
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.294
Gnomad AMI
AF:
0.313
Gnomad AMR
AF:
0.288
Gnomad ASJ
AF:
0.255
Gnomad EAS
AF:
0.280
Gnomad SAS
AF:
0.393
Gnomad FIN
AF:
0.300
Gnomad MID
AF:
0.271
Gnomad NFE
AF:
0.302
Gnomad OTH
AF:
0.278
GnomAD2 exomes
AF:
0.257
AC:
3585
AN:
13926
AF XY:
0.245
show subpopulations
Gnomad AFR exome
AF:
0.192
Gnomad AMR exome
AF:
0.122
Gnomad ASJ exome
AF:
0.100
Gnomad EAS exome
AF:
0.180
Gnomad FIN exome
AF:
0.302
Gnomad NFE exome
AF:
0.172
Gnomad OTH exome
AF:
0.164
GnomAD4 exome
AF:
0.304
AC:
348776
AN:
1145802
Hom.:
53827
Cov.:
34
AF XY:
0.304
AC XY:
166475
AN XY:
548400
show subpopulations
African (AFR)
AF:
0.293
AC:
6839
AN:
23332
American (AMR)
AF:
0.280
AC:
2757
AN:
9850
Ashkenazi Jewish (ASJ)
AF:
0.240
AC:
3759
AN:
15656
East Asian (EAS)
AF:
0.269
AC:
7195
AN:
26774
South Asian (SAS)
AF:
0.335
AC:
11335
AN:
33788
European-Finnish (FIN)
AF:
0.292
AC:
11257
AN:
38486
Middle Eastern (MID)
AF:
0.256
AC:
859
AN:
3358
European-Non Finnish (NFE)
AF:
0.307
AC:
290780
AN:
948676
Other (OTH)
AF:
0.305
AC:
13995
AN:
45882
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
13120
26240
39359
52479
65599
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10972
21944
32916
43888
54860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.299
AC:
45311
AN:
151538
Hom.:
6867
Cov.:
33
AF XY:
0.300
AC XY:
22202
AN XY:
74058
show subpopulations
African (AFR)
AF:
0.294
AC:
12141
AN:
41296
American (AMR)
AF:
0.288
AC:
4397
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.255
AC:
885
AN:
3466
East Asian (EAS)
AF:
0.280
AC:
1412
AN:
5036
South Asian (SAS)
AF:
0.393
AC:
1891
AN:
4812
European-Finnish (FIN)
AF:
0.300
AC:
3160
AN:
10528
Middle Eastern (MID)
AF:
0.274
AC:
80
AN:
292
European-Non Finnish (NFE)
AF:
0.302
AC:
20477
AN:
67814
Other (OTH)
AF:
0.277
AC:
583
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1668
3336
5004
6672
8340
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
464
928
1392
1856
2320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
TOPMed (Bravo)
AF:
0.296
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF:
0.212
AC:
7251
AN:
34150
Hom.:
1070

Local populations

ABraOM SABE-WGS-1171
AF:
0.291
AC:
682
AN:
2342
Hom.:
92
ChinaMAP Phase 1
AF:
0.304
Denmark Genome
AF:
0.317
AC:
95
AN:
300
GenomeAsia100K
AF:
0.337
AC:
1170
AN:
3464
show subpopulations
Oceania
AF:
0.205
AC:
30
AN:
146
Hom.:
5
North-East Asia
AF:
0.283
AC:
199
AN:
702
Hom.:
24
South-East Asia
AF:
0.259
AC:
179
AN:
690
Hom.:
28
South Asia
AF:
0.428
AC:
620
AN:
1448
Hom.:
149
Africa
AF:
0.260
AC:
53
AN:
204
Hom.:
4
America
AF:
0.420
AC:
21
AN:
50
Hom.:
5
West Eurasia
AF:
0.304
AC:
68
AN:
224
Hom.:
11
Korea4K (4,157 Koreans)
AF:
0.275
AC:
1972
AN:
7174
Qatari Genome
AF:
0.295
AC:
52
AN:
176
ToMMo 61KJPN (+60KJPN MNV)
AF:
0.277
AC:
33747
AN:
121754
Hom.:
4753
Turkish Variome
AF:
0.276
AC:
426
AN:
1546
Hom.:
66
UK10K
AF:
0.318
AC:
2406
AN:
7562
show subpopulations
TwinsUK
AF:
0.315
AC:
1126
AN:
3574
ALSPAC
AF:
0.320
AC:
1232
AN:
3854
WBBC (Westlake BioBank for Chinese) pilot
AF:
0.292
AC:
2618
AN:
8960
Hom.:
372

Case/control cohorts

Cohort
Cases
Controls
SCHEMA
(Schizophrenia)
39170 / 118816AF: 0.329669
62020 / 179310AF: 0.345881

Allele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
not specified (7)
-
-
1
Congenital Muscular Dystrophy, alpha-dystroglycan related (1)
-
-
1
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7 (1)
-
-
1
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7;C5190987:Autosomal recessive limb-girdle muscular dystrophy type 2U (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.095
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
3.4
DANN
Benign
0.79
DEOGEN2
Benign
0.0014
T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.062
N
LIST_S2
Benign
0.48
T
MetaRNN
Benign
0.0037
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N
PhyloP100
-1.7
PrimateAI
Uncertain
0.75
T
PROVEAN
Benign
-0.20
N
REVEL
Benign
0.14
Sift
Benign
0.88
T
Sift4G
Benign
0.66
T
PromoterAI
0.12
Neutral
Varity_R
0.046
popEVE
Benign
-3.0
VESM-3B
Benign
-2.4
FuncVEP CTI
Benign
0.0019
AlphaGenome AVI
Benign
5.2
GPN-Star LLR
-1.1
GPN-Star score
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2
Pangolin (max)
Benign
0.0

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.